6-MAPDB
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
6-MAPDB, also known as 6-(2-(methylamino)propyl)-2,3-dihydrobenzofuran, is a chemical compound which may be an entactogen of the dihydrobenzofuran family. It is structurally related to drugs like 6-APDB and 6-MAPB, which have similar effects to MDMA and have been used as recreational drugs. 6-MAPDB has never been studied to determine its pharmacological activity, though it is the N-methyl derivative of 6-APDB which is known to be a selective serotonin releaser.
6-MAPDB, also known as 6-(2-(methylamino)propyl)-2,3-dihydrobenzofuran, is a chemical compound which may be an entactogen of the dihydrobenzofuran family. It is structurally related to drugs like 6-APDB and 6-MAPB, which have similar effects to MDMA and have been used as recreational drugs. 6-MAPDB has never been studied to determine its pharmacological activity, though it is the N-methyl derivative of 6-APDB which is known to be a selective serotonin releaser. ==Interactions== ==Society and culture== ===Legal status=== 6-MAPDB was banned in the UK in June 2013 as a temporary class drug along with 9 other related compounds, despite having never been sold as a street drug itself. This was due to concerns that it would have similar effects to drugs such as 6-APB that had been widely sold already, and 6-MAPDB might therefore be likely to become used recreationally, if it were not banned preemptively. ==See also== Substituted benzofuran 5-MAPDB 5-MAPDI IBF5MAP ==References== ==External links== 6-MAPDB - Isomer Design
Text derived from https://en.wikipedia.org/w/index.php?oldid=1376470418 under CC BY-SA 4.0; modifications have been made.